97
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Enhanced oral delivery of risperidone through a novel self-nanoemulsifying powder (SNEP) formulations: in-vitro and ex-vivo assessment

, &
Pages 544-553 | Received 24 Dec 2015, Accepted 05 Aug 2016, Published online: 28 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dharmesh Gol, Shreya Thakkar & Manju Misra. (2018) Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization. Drug Development and Industrial Pharmacy 44:9, pages 1458-1466.
Read now
Reema Narayan, Abhyuday Pednekar, Dipshikha Bhuyan, Chaitra Gowda, KB Koteshwara & Usha Yogendra Nayak. (2017) A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. International Journal of Nanomedicine 12, pages 4921-4935.
Read now

Articles from other publishers (2)

Lena Dalal, Abdul Wahab Allaf & Hind El-Zein. (2021) Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide. Scientific Reports 11:1.
Crossref
Sedat Bilgiç, Deniz Taştemir Korkmaz, Sebile Azirak, Ayşe Nilay Güvenç, Nevin Kocaman & Mehmet Kaya Özer. (2017) Risperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of Resveratrol. Oxidative Medicine and Cellular Longevity 2017, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.